• Home
  • News
  • Politics
  • Business
  • Entertainment
  • Education
  • Health
  • Opinion
  • Sports
  • More…
    • About
    • Privacy Policy
    • Advertise
Saturday, November 21, 2026
  • Login
No Result
View All Result
NEWSLETTER
Elanza News
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Education
  • Health
  • Opinion
  • Sports
  • More…
    • About
    • Privacy Policy
    • Advertise
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Education
  • Health
  • Opinion
  • Sports
  • More…
    • About
    • Privacy Policy
    • Advertise
No Result
View All Result
Elanza News
Home News

NAFDAC alerts Nigerians on fake cancer treatment drugs

Nathaniel Irobi by Nathaniel Irobi
January 5, 2025
in News
0
0
SHARES
23
VIEWS
FacebookTwitterWhatsappEmailTelegram

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, including healthcare providers, about a counterfeit cancer treatment drug, Phesgo 600mg/600mg/10ml, labelled with batch number C5290S20.

This notification is outlined in a public alert (No. 051/2024) available on the agency’s website.

RelatedPosts

Ex-APC senatorial aspirant condemns attack on Rarara, threats against Tinubu supporters

Zamfara 2027: Bilyaminu Shinkafi unveils 2,500-member ADC council, prioritises security

Tinubu 2027: Arewa Youths Unveil Northern Mobilization Plan After Abuja Meeting With Faleke

NAFDAC reported that the Marketing Authorisation Holder (MAH), Roche, received a complaint from a doctor at the Lagos University Teaching Hospital (LUTH-NSIA) regarding the suspected counterfeit product.

The Phesgo 600mg/600mg, labelled with batch number C5290S20, was reported to have been brought in by a patient for administration.

The agency disclosed that, at the time of the report the product had not been administered, but it matched the characteristics of a previously reported counterfeit batch, C3809C51.

“Although no physical sample was returned to Roche for investigation, images of parts of the product specifically, a Phesgo 600mg/600mg vial and a 10ml folding box were examined.

“The suspected product’s images were compared to genuine samples retained by Roche.

“Roche’s investigation identified several significant differences between the complaint sample and genuine materials, confirming the counterfeit status of the batch.

“These included: no batch number in the MAH database, discrepancies in language, missing basilisk, incorrect bollino date, and tamper evidence labels that did not match genuine Roche materials.

“Since no physical sample was available for chemical analysis, the investigation was limited to visual comparisons,” it said.

ALSO READ:  FG hands over 64 CNG buses to labour unions, NANS

NAFDAC explained that Phesgo 600mg/600mg Solution for Injection is used to treat breast cancer, as it works by killing cancer cells and preventing their further growth.

The agency emphasised that illegal marketing of counterfeit medicines was a serious health risk, as these products might not comply with regulatory standards and could undermine safety, quality, and effectiveness.

The agency had instructed all NAFDAC zonal directors and state coordinators to carry out surveillance and remove counterfeit products from their zones and states.

NAFDAC also advised importers, distributors, retailers, healthcare professionals, and caregivers to be cautious and vigilant throughout the supply chain, avoiding the importation, distribution, and sale of counterfeit products.

It emphasised that medical products should only be obtained from authorised and licensed suppliers, with careful checks on their authenticity and physical condition.

“Healthcare professionals and consumers are urged to report any suspicions of substandard or falsified medicines or medical devices to the nearest NAFDAC office.

“Reports can also be made through NAFDAC’s contact number (0800-162-3322) or via email at sf.alert@nafdac.gov.ng.

“Additionally, healthcare professionals and patients are encouraged to report any adverse events or side effects related to the use of medicinal products or devices.

“NAFDAC provides e-reporting platforms on its website (www.nafdac.gov.ng) and through the Med-Safety app, available for download on Android and iOS devices.”

The agency said adverse effects could also be reported via email at pharmacovigilance@nafdac.gov.ng.

NAFDAC said the product notification would also be uploaded to the World Health Organisation (WHO) Global Surveillance and Monitoring System (GSMS).”

Tags: Cancer
Previous Post

Gov Uba Sani’s Aide, Rachael Averik, Escapes Assassination Attempt

Next Post

NAF increases feeding fees, introduces accident policy for personnel

Nathaniel Irobi

Nathaniel Irobi

Related Posts

Ex-APC senatorial aspirant condemns attack on Rarara, threats against Tinubu supporters

Ex-APC senatorial aspirant condemns attack on Rarara, threats against Tinubu supporters

by Ojimaojo Abubakar
November 21, 2026
0

Former Imo East APC Senatorial aspirant, Hon. Belusochukwu Enwere, has condemned alleged threats and attacks against supporters of President Bola...

Zamfara 2027: Bilyaminu  Shinkafi unveils 2,500-member ADC council, prioritises security

Zamfara 2027: Bilyaminu Shinkafi unveils 2,500-member ADC council, prioritises security

by Ojimaojo Abubakar
November 19, 2026
0

The governorship candidate of the African Democratic Congress in Zamfara State, Bilyaminu Yusuf Shinkafi, has unveiled a 2,500-member campaign council...

Tinubu 2027: Arewa Youths Unveil Northern Mobilization Plan After Abuja Meeting With Faleke

Tinubu 2027: Arewa Youths Unveil Northern Mobilization Plan After Abuja Meeting With Faleke

by Ojimaojo Abubakar
November 19, 2026
0

By Nahum Sule, Jalingo The President of Arewa Youths, Alhaji Danbature Abdul-Hamid, has briefed Rt. Hon. James Abiodun Faleke, Deputy...

Next Post
NAF increases feeding fees, introduces accident policy for personnel

NAF increases feeding fees, introduces accident policy for personnel

Assassination: APC warns PDP against reckless allegations

Assassination: APC warns PDP against reckless allegations

Recommended

Ex-APC senatorial aspirant condemns attack on Rarara, threats against Tinubu supporters

Ex-APC senatorial aspirant condemns attack on Rarara, threats against Tinubu supporters

2 hours ago
Union Hails Tinubu, Uba Sani, Demands Better Welfare

Union Hails Tinubu, Uba Sani, Demands Better Welfare

7 days ago

Popular News

  • Residents flee as flood ravages 10 communities in Kebbi – NEMA

    Residents flee as flood ravages 10 communities in Kebbi – NEMA

    0 shares
    Share 0 Tweet 0
  • Drama In FCT Polls As APC, PDP Candidates Step Down For Each Other

    0 shares
    Share 0 Tweet 0
  • Boost Military Morale Through Positive Coverage, Media Told

    0 shares
    Share 0 Tweet 0
  • 2027: Arewa youth leader plans Northern mobilisation for Tinubu

    0 shares
    Share 0 Tweet 0
  • BOOK REVIEW :Digital Shift in Nigeria’s Newspaper Industry;By Sunday Isuwa, PhD

    0 shares
    Share 0 Tweet 0

Connect with us

Facebook Instagram Twitter Youtube
Elanza logo

Elanza News is your NO 1 online platform for all news update.
#SayNoToFakeNews
Contact Us

Category

  • Arts & Literature (26)
  • Business (884)
  • Education (288)
  • Entertainment (475)
  • Health (261)
  • National (3,595)
  • News (11,365)
  • Opinion (511)
  • Politics (2,372)
  • Science (15)
  • Security (423)
  • Sports (795)

Newsletter

© 2023 Elanza News - The No 1 online news platform

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Politics
  • Business
  • Science
  • National
  • Entertainment
  • Sports
  • Health

© 2023 Elanza News - The No 1 online news platform